Phase I trial of 90Y-DOTATOC therapy in children and young adults with refractory solid tumors that express somatostatin receptors - Menda, Yusuf; O'Dorisio, M Sue; Kao, Simon; Khanna, Geetika; Michael, Stacy; Connolly, Mary; Babich, John; O'Dorisio, Thomas; Bushnell, David; Madsen, Mark (The Journal of nuclear medicine (1978), 2010)
Keywords: Adolescent; Adult; Child; Child, Preschool; Female; Humans; Male; Maximum Tolerated Dose; Neoplasms - metabolism; Neoplasms - radiotherapy; Octreotide - adverse effects; Octreotide - analogs & derivatives; Octreotide - pharmacokinetics; Octreotide - therapeutic use; Radiation Injuries - diagnosis; Radiation Injuries - etiology; Radiation Injuries - metabolism; Radiopharmaceuticals - adverse effects; Radiopharmaceuticals - pharmacokinetics; Radiopharmaceuticals - therapeutic use; Receptors, Somatostatin - metabolism; Risk Assessment; Young Adult